Your browser doesn't support javascript.
loading
Dupilumab combined with low-dose systemic steroid therapy improves efficacy and safety for bullous pemphigoid.
Yang, Jin; Gao, Haiqing; Zhang, Zhen; Tang, Chang; Chen, Zihua; Wang, Lanting; Yang, Fanping; Chen, Shengan; He, Shan; Liu, Shutao; Tang, Lin; Xu, Yu; Hu, Yao; Ma, Li; Zhao, Ying; Luo, Xiaoqun.
Affiliation
  • Yang J; Department of Allergy & Immunology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Gao H; Department of Dermatology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Zhang Z; Department of Allergy & Immunology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Tang C; Department of Dermatology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Chen Z; Department of Allergy & Immunology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Wang L; Department of Dermatology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Yang F; Department of Allergy & Immunology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Chen S; Department of Dermatology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • He S; Department of Allergy & Immunology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Liu S; Department of Dermatology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Tang L; Department of Allergy & Immunology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Xu Y; Department of Dermatology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Hu Y; Department of Allergy & Immunology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Ma L; Department of Dermatology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Zhao Y; Department of Allergy & Immunology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
  • Luo X; Department of Dermatology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
Dermatol Ther ; 35(8): e15648, 2022 08.
Article de En | MEDLINE | ID: mdl-35715972

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pemphigoïde bulleuse Type d'étude: Diagnostic_studies / Observational_studies Limites: Humans Langue: En Journal: Dermatol Ther Sujet du journal: DERMATOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pemphigoïde bulleuse Type d'étude: Diagnostic_studies / Observational_studies Limites: Humans Langue: En Journal: Dermatol Ther Sujet du journal: DERMATOLOGIA Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique